MY8700945A - Carbapenem antibiotics - Google Patents

Carbapenem antibiotics

Info

Publication number
MY8700945A
MY8700945A MY945/87A MY8700945A MY8700945A MY 8700945 A MY8700945 A MY 8700945A MY 945/87 A MY945/87 A MY 945/87A MY 8700945 A MY8700945 A MY 8700945A MY 8700945 A MY8700945 A MY 8700945A
Authority
MY
Malaysia
Prior art keywords
carbapenem antibiotics
carbapenem
antibiotics
Prior art date
Application number
MY945/87A
Other languages
English (en)
Inventor
Choung Un Kim
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of MY8700945A publication Critical patent/MY8700945A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MY945/87A 1982-04-08 1987-12-30 Carbapenem antibiotics MY8700945A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36662782A 1982-04-08 1982-04-08

Publications (1)

Publication Number Publication Date
MY8700945A true MY8700945A (en) 1987-12-31

Family

ID=23443823

Family Applications (1)

Application Number Title Priority Date Filing Date
MY945/87A MY8700945A (en) 1982-04-08 1987-12-30 Carbapenem antibiotics

Country Status (25)

Country Link
JP (1) JPS58188887A (da)
KR (1) KR880001055B1 (da)
AT (1) AT383126B (da)
AU (1) AU567092B2 (da)
BE (1) BE896407A (da)
CA (1) CA1198440A (da)
CH (1) CH661927A5 (da)
DE (1) DE3312517A1 (da)
DK (1) DK155983A (da)
ES (1) ES521224A0 (da)
FI (1) FI74009C (da)
FR (1) FR2524888B1 (da)
GB (1) GB2118183B (da)
GR (1) GR78822B (da)
HU (1) HU190716B (da)
IE (1) IE55225B1 (da)
IL (1) IL68295A0 (da)
IT (1) IT1168854B (da)
LU (1) LU84739A1 (da)
MY (1) MY8700945A (da)
NL (1) NL8301193A (da)
OA (1) OA07395A (da)
PT (1) PT76518B (da)
SE (1) SE460197B (da)
ZA (1) ZA832411B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
AT396473B (de) * 1984-10-02 1993-09-27 Bristol Myers Squibb Co Verfahren zur herstellung von neuen carbapenemderivaten
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
EP0082133A3 (en) * 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
EP0038869A1 (en) * 1980-04-30 1981-11-04 Merck & Co. Inc. Process for the preparation of 1-carbapenems, and intermediates for their preparation
HU185493B (en) * 1981-12-30 1985-02-28 Richter Gedeon Vegyeszet Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptene derivatives
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics

Also Published As

Publication number Publication date
FI831135A0 (fi) 1983-04-05
JPS58188887A (ja) 1983-11-04
ATA125583A (de) 1986-10-15
IT8348061A0 (it) 1983-04-07
ZA832411B (en) 1983-12-28
KR880001055B1 (ko) 1988-06-18
PT76518B (en) 1986-02-06
IT1168854B (it) 1987-05-20
NL8301193A (nl) 1983-11-01
GB8309505D0 (en) 1983-05-11
CA1198440A (en) 1985-12-24
SE460197B (sv) 1989-09-18
KR840004429A (ko) 1984-10-15
DK155983D0 (da) 1983-04-07
DE3312517C2 (da) 1991-10-31
IL68295A0 (en) 1983-07-31
HU190716B (en) 1986-10-28
AT383126B (de) 1987-05-25
GB2118183A (en) 1983-10-26
ES8405399A1 (es) 1984-06-01
DK155983A (da) 1983-10-09
FI831135L (fi) 1983-10-09
FR2524888A1 (fr) 1983-10-14
AU1319883A (en) 1983-10-13
GR78822B (da) 1984-10-02
DE3312517A1 (de) 1983-10-20
GB2118183B (en) 1985-11-27
OA07395A (fr) 1984-06-30
AU567092B2 (en) 1987-11-12
LU84739A1 (fr) 1983-12-05
SE8301928D0 (sv) 1983-04-07
BE896407A (fr) 1983-10-07
CH661927A5 (de) 1987-08-31
FR2524888B1 (fr) 1985-12-13
FI74009C (fi) 1987-12-10
IE830800L (en) 1983-10-08
JPH0524156B2 (da) 1993-04-06
FI74009B (fi) 1987-08-31
SE8301928L (sv) 1983-12-02
PT76518A (en) 1983-05-01
ES521224A0 (es) 1984-06-01
IE55225B1 (en) 1990-07-04

Similar Documents

Publication Publication Date Title
GB2122196B (en) Carbapenem antibiotics
ZA837974B (en) Xenorhabdin antibiotics
GB2119371B (en) Carbapenem antibiotics
GB2128187B (en) Carbapenem antibiotics
GB8307807D0 (en) Antibiotics
ZA836966B (en) Carbapenem antibiotics
GB2118183B (en) Carbapenem antibiotics
GB2123414B (en) Cephalosporin antibiotics
ZA832412B (en) Carbapenem antibiotics
GB2132193B (en) Cephalosporin antibiotics
DE3372208D1 (en) Beta-lactam antibiotics
ZA831461B (en) Antibiotics
ZA833616B (en) Cephalosporin antibiotics
GB2129429B (en) B-lactam antibiotics
GB8528958D0 (en) Antibiotics
ZA834472B (en) Carbepenem antibiotics
PT76959A (en) Cephalosporin antibiotics
GB8620344D0 (en) Antibiotics
GB2113672B (en) Antibiotic
IL69109A0 (en) Cephalosporin antibiotics
IL69108A0 (en) Cephalosporin antibiotics
IE820546L (en) Cephalosporin antibiotics